AKT1 and adult T-cell leukemia/lymphoma: Expression of NDRG2 is frequently downregulated in adult T-cell leukemia-lymphoma (ATLL), resulting in enhanced phosphorylation in C-tail of PTEN and enhanced activation of the PI3K–AKT pathway (117).